
Jefferies lowered its price target on Ultragenyx Pharma stock to $63 on the trial miss
Source link
Needham reiterates Buy on Braze stock, names it top pick for 2026
Needham reiterates Buy on Braze stock, names it top pick for 2026 Source link

Jefferies lowered its price target on Ultragenyx Pharma stock to $63 on the trial miss
Source link
Needham reiterates Buy on Braze stock, names it top pick for 2026 Source link
Tower Semiconductor downgraded to Neutral due to Rating: Wedbush Source link